Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients

Complement Ther Med. 2015 Oct;23(5):652-7. doi: 10.1016/j.ctim.2015.07.003. Epub 2015 Jul 17.

Abstract

Background: The effect of nutrition and dietary supplements as environmental factors has been suggested as possible factors affecting both disease risk and progression in on the course of multiple sclerosis with complex genetic-risk profiles. This study was aimed to assess regulation of surface-membrane enzymes such as Delta-6-desaturase (FADS2), secretory Phospholipase A2(sPLA2) by hemp seed and evening primrose oils as well as Hot-natured dietary intervention in relapsing remitting multiple sclerosis (RRMS) patients.

Methods and materials: In this double blind, randomized trial, 100 RRMS patients with Extended disability status score (EDSS)<6 were allocated into 3 groups: "Group A" who received co-supplemented hemp seed and evening primrose oils along with advised Hot nature diet; "Group B", who received olive oil; "Group C", who received the co-supplemented oils. Clinically EDSS and functional score as well as biochemical parameters [blood cells polyunsaturated fatty acid (PUFA), FADS2, sPLA2] were assessed at baseline and after 6 months.

Results: Mean follow-up was 180±2.9SD days (N=65, 23 M and 42 F aged 34.25±8.07 years with disease duration 6.80±4.33 years). There was no significant difference in studies parameters at baseline. After 6 months, significant improvements in EDSS and functional score were found in the groups A and C while EDSS and pyramidal score showed significant increase in group B. Alteration of biochemical parameters showed improvement in groups A and C whereas there was worsening condition for group B after the intervention.

Conclusion: The co-supplemented hemp seed and evening primrose oils with Hot nature diet can have beneficial effects in improving clinical symptoms and signs in RRMS patients which were confirmed by regulation of surface-membrane enzymes.

Keywords: Cannabis sativa L; Delta-6-desaturase (FADS2); Oenothera biennis L; Polyunsaturated fatty acid (PUFA); Relapsing remitting multiple sclerosis (RRMS); Secretory phospholipase A2 (sPLA2).

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cannabis*
  • Double-Blind Method
  • Fatty Acid Desaturases / blood*
  • Female
  • Humans
  • Linoleic Acids / administration & dosage
  • Linoleic Acids / therapeutic use*
  • Male
  • Multiple Sclerosis / diet therapy*
  • Oenothera biennis
  • Phospholipases A2, Secretory / blood*
  • Plant Oils / administration & dosage
  • Plant Oils / therapeutic use*
  • Seeds*
  • gamma-Linolenic Acid / administration & dosage
  • gamma-Linolenic Acid / therapeutic use*

Substances

  • Linoleic Acids
  • Plant Oils
  • evening primrose oil
  • gamma-Linolenic Acid
  • Fatty Acid Desaturases
  • FADS2 protein, human
  • Phospholipases A2, Secretory